Nasopharyngeal swab is the reference sampling method to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as recommended by the World Health Organization (WHO) (1). However, nasal specimens may have a slightly lower sensitivity than nasopharyngeal specimens (2, 3). We herein validated an alternative procedure to collect nasal secretions with a swab routinely used in medical bacteriology for which there is no risk of supply disruption in order to perform the molecular diagnosis of SARS-CoV-2 infection.
Full Scientific Study
October 22, 2020
Journal of Clinical Microbiology
Hélène Péré
Isabelle Podglajen
Maxime Wack
Edouard Flamarion
Tristan Mirault
Guillaume Goudot
Caroline Hauw-Berlemont
Laetitia Le
Eric Caudron
Sophie Carrabin
Julien Rodary
Tatiana Ribeyre
Laurent Bélec
David Veyera
No results
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.